Gerald S. Marks

5.5k total citations
210 papers, 4.6k citations indexed

About

Gerald S. Marks is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Gerald S. Marks has authored 210 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Molecular Biology, 48 papers in Pediatrics, Perinatology and Child Health and 47 papers in Pharmacology. Recurrent topics in Gerald S. Marks's work include Porphyrin Metabolism and Disorders (77 papers), Heme Oxygenase-1 and Carbon Monoxide (71 papers) and Pharmacogenetics and Drug Metabolism (45 papers). Gerald S. Marks is often cited by papers focused on Porphyrin Metabolism and Disorders (77 papers), Heme Oxygenase-1 and Carbon Monoxide (71 papers) and Pharmacogenetics and Drug Metabolism (45 papers). Gerald S. Marks collaborates with scholars based in Canada, United States and Italy. Gerald S. Marks's co-authors include Brian E. McLaughlin, James F. Brien, Kanji Nakatsu, Paul W. Armstrong, K. Nakatsu, James F. Brien, Susan P.C. Cole, Kanji Nakatsu, Francesco De Matteis and Brian M. Bennett and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Gerald S. Marks

207 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald S. Marks Canada 35 2.5k 1.0k 988 618 572 210 4.6k
James F. Brien Canada 37 1.8k 0.7× 487 0.5× 2.2k 2.2× 702 1.1× 367 0.6× 202 4.9k
Roland C. Blantz United States 47 2.1k 0.8× 1.8k 1.7× 695 0.7× 217 0.4× 1.4k 2.5× 177 7.4k
Alberto Nasjletti United States 49 3.0k 1.2× 1.8k 1.7× 703 0.7× 534 0.9× 2.1k 3.7× 183 7.1k
V. Ullrich Germany 30 1.4k 0.6× 770 0.7× 277 0.3× 168 0.3× 176 0.3× 81 3.3k
Ryuichi Kikkawa Japan 55 3.4k 1.4× 2.2k 2.1× 324 0.3× 172 0.3× 1.3k 2.2× 210 9.0k
Toyoshi Inoguchi Japan 46 3.0k 1.2× 2.3k 2.2× 499 0.5× 142 0.2× 1.4k 2.4× 147 8.3k
Didier Morin France 38 2.5k 1.0× 474 0.5× 271 0.3× 155 0.3× 388 0.7× 160 4.7k
Akihiro Tojo Japan 45 1.5k 0.6× 1.6k 1.5× 614 0.6× 115 0.2× 1.4k 2.5× 141 5.9k
Tianxin Yang United States 52 3.4k 1.3× 1.4k 1.3× 423 0.4× 334 0.5× 1.8k 3.1× 170 7.9k
Giuseppe Paradies Italy 49 5.3k 2.1× 1.7k 1.6× 213 0.2× 555 0.9× 465 0.8× 87 7.5k

Countries citing papers authored by Gerald S. Marks

Since Specialization
Citations

This map shows the geographic impact of Gerald S. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald S. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald S. Marks more than expected).

Fields of papers citing papers by Gerald S. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald S. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald S. Marks. The network helps show where Gerald S. Marks may publish in the future.

Co-authorship network of co-authors of Gerald S. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald S. Marks. A scholar is included among the top collaborators of Gerald S. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald S. Marks. Gerald S. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Appleton, Scott, Gendie E. Lash, Gerald S. Marks, et al.. (2003). Effect of glucose and oxygen deprivation on heme oxygenase expression in human chorionic villi explants and immortalized trophoblast cells. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 285(6). R1453–R1460. 16 indexed citations
3.
McLaughlin, Brian E., Gendie E. Lash, Charles H. Graham, et al.. (2001). Endogenous Carbon Monoxide Formation by Chorionic Villi of Term Human Placenta. Placenta. 22(10). 886–888. 7 indexed citations
4.
Graham, Charles H., Karen Kimura, Brian E. McLaughlin, et al.. (1998). Heme oxygenase and nitric oxide synthase in the placenta of the guinea-pig during gestation. Placenta. 19(7). 509–516. 39 indexed citations
6.
Coceani, Flavio, Lois Kelsey, Eric Seidlitz, et al.. (1997). Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. British Journal of Pharmacology. 120(4). 599–608. 86 indexed citations
7.
McNamee, James P., et al.. (1994). Evidence for mechanism-based inactivation of rat and chick embryo hepatic cytochrome P4501A and P4503A by dihydropyridines, sydnones, and dihydroquinolines. Biochemical Pharmacology. 47(11). 2069–2078. 11 indexed citations
8.
Liu, Zhenguo, et al.. (1993). Selective sequestration of nitric oxide by subcellular components of vascular smooth muscle and platelets: relationship to nitric oxide stimulation of the soluble guanylyl cyclase. Canadian Journal of Physiology and Pharmacology. 71(12). 938–945. 10 indexed citations
9.
Marks, Gerald S., Brian E. McLaughlin, Kanji Nakatsu, & James F. Brien. (1992). Biotransformation of glyceryl trinitrate by rat brain homogenate. Canadian Journal of Physiology and Pharmacology. 70(6). 935–937. 9 indexed citations
10.
Marks, Gerald S., Brian E. McLaughlin, Kanji Nakatsu, & James F. Brien. (1992). Direct evidence for nitric oxide formation from glyceryl trinitrate during incubation with intact bovine pulmonary artery. Canadian Journal of Physiology and Pharmacology. 70(2). 308–311. 38 indexed citations
11.
Marks, Gerald S., et al.. (1992). Inhibition of chick embryo hepatic uroporphyrinogen decarboxylase by components of xenobiotic-treated chick embryo hepatocytes in culture. II.. Canadian Journal of Physiology and Pharmacology. 70(7). 939–942. 5 indexed citations
12.
Mackie, Jane E., et al.. (1990). Effects of 3-(2-phenylethyl)-4-methylsydnone and related sydnones on heme biosynthesis. Biochemical Pharmacology. 39(11). 1767–1774. 5 indexed citations
13.
14.
McCluskey, Stuart A., Ralph A. Whitney, & Gerald S. Marks. (1989). Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins.. Molecular Pharmacology. 36(4). 608–614. 8 indexed citations
15.
Marks, Gerald S., et al.. (1989). Differential biotransformation of glyceryl trinitrate by red blood cell – supernatant fraction and pulmonary vein homogenate. Canadian Journal of Physiology and Pharmacology. 67(5). 417–422. 10 indexed citations
16.
Mackie, Jane E. & Gerald S. Marks. (1989). Synergistic induction of δ-aminolevulinic acid synthase activity by N-ethylprotoporphyrin IX and 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-isobutylpyridine. Biochemical Pharmacology. 38(13). 2169–2173. 7 indexed citations
17.
Marks, Gerald S., Jane E. Mackie, Stuart A. McCluskey, & David S. Riddick. (1989). Regulation of Heme Biosynthesis in Chick Embryo Liver Cells. Advances in experimental medicine and biology. 271. 123–133. 3 indexed citations
18.
Brien, James F., et al.. (1988). Mechanism of glyceryl trinitrate-induced vasodilation. II. Lack of evidence for specific binding of GTN to bovine pulmonary vein.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 328–334. 6 indexed citations
19.
Nakatsu, Kanji, et al.. (1988). A facile, reliable method for staining blood vessel endothelium. Journal of Pharmacological Methods. 19(2). 149–154. 6 indexed citations
20.
Cook, David, et al.. (1971). Studies of the chemical nature of the α-adrenergic receptor—V. Biochemical Pharmacology. 20(3). 597–603. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026